ArticleTranslational lung cancer research2023

Impact of ramucirumab plus erlotinib on circulating cell-free DNA from patients with untreated metastatic non-small cell lung cancer with

Kazuto Nishio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.